291 related articles for article (PubMed ID: 34122337)
1. Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment.
Zhou YJ; Wang QW; Zhang QW; Chen JN; Wang XY; Gao YJ; Li XB
Front Endocrinol (Lausanne); 2021; 12():658392. PubMed ID: 34122337
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of endoscopic treatment and predictors of lymph node metastasis in early gastric cancer.
Chu YN; Yu YN; Jing X; Mao T; Chen YQ; Zhou XB; Song W; Zhao XZ; Tian ZB
World J Gastroenterol; 2019 Sep; 25(35):5344-5355. PubMed ID: 31558878
[TBL] [Abstract][Full Text] [Related]
3. Risk of lymph node metastasis after endoscopic treatment for rectal NETs 10 mm or less.
Inada Y; Yoshida N; Fukumoto K; Hirose R; Inoue K; Dohi O; Murakami T; Ogiso K; Tomie A; Kugai M; Yoriki H; Inagaki Y; Hasegawa D; Okuda K; Okuda T; Morinaga Y; Kishimoto M; Itoh Y
Int J Colorectal Dis; 2021 Mar; 36(3):559-567. PubMed ID: 33388960
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.
Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y
Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study.
Chen L; Tang K; Wang S; Chen D; Ding K
Cancer Control; 2021; 28():10732748211026668. PubMed ID: 34155922
[TBL] [Abstract][Full Text] [Related]
6. Large population-based study using the SEER database: is endoscopic resection appropriate for early gastric cancer patients in the United States?
Yang B; Sun K; Hui Y; Zhu L; Wang S; Ma S; Yu Z; Zhao J; Liu Q; Zhao J; Chen X
Scand J Gastroenterol; 2020 Jul; 55(7):834-842. PubMed ID: 32649237
[TBL] [Abstract][Full Text] [Related]
7. Is endoscopic resection appropriate for type 3 gastric neuroendocrine tumors? Retrospective multicenter study.
Hirasawa T; Yamamoto N; Sano T
Dig Endosc; 2021 Mar; 33(3):408-417. PubMed ID: 32578248
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China.
Chen X; Li B; Wang S; Yang B; Zhu L; Ma S; Wu J; He Q; Zhao J; Zheng Z; Li S; Wang T; Liang L
Scand J Gastroenterol; 2019 Mar; 54(3):384-389. PubMed ID: 31037980
[No Abstract] [Full Text] [Related]
9. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
10. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.
Li QL; Zhang YQ; Chen WF; Xu MD; Zhong YS; Ma LL; Qin WZ; Hu JW; Cai MY; Yao LQ; Zhou PH
World J Gastroenterol; 2012 Oct; 18(40):5799-806. PubMed ID: 23155323
[TBL] [Abstract][Full Text] [Related]
12. Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer.
Liang XQ; Wang Z; Li HT; Ma G; Yu WW; Zhou HC; Liu HB
Asian J Surg; 2020 Oct; 43(10):973-977. PubMed ID: 31964584
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for lymph node metastasis and long-term outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection.
Kawata N; Kakushima N; Takizawa K; Tanaka M; Makuuchi R; Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Sugino T; Kusafuka K; Shimoda T; Nakajima T; Terashima M; Ono H
Surg Endosc; 2017 Apr; 31(4):1607-1616. PubMed ID: 27495338
[TBL] [Abstract][Full Text] [Related]
15. Lymph node metastasis can be determined by just tumor depth and lymphovascular invasion in early gastric cancer patients after endoscopic submucosal dissection.
Goto A; Nishikawa J; Hideura E; Ogawa R; Nagao M; Sasaki S; Kawasato R; Hashimoto S; Okamoto T; Ogihara H; Hamamoto Y; Sakaida I
Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1346-1350. PubMed ID: 29084076
[TBL] [Abstract][Full Text] [Related]
16. Risk of lymph node metastasis in early gastric cancer and indications for endoscopic resection: is it worth applying the east rules to the west?
Milhomem LM; Milhomem-Cardoso DM; da Mota OM; Mota ED; Kagan A; Filho JBS
Surg Endosc; 2021 Aug; 35(8):4380-4388. PubMed ID: 32880748
[TBL] [Abstract][Full Text] [Related]
17. Prediction of the indication criteria for endoscopic resection of early gastric cancer.
Park JH; Lee SH; Park JM; Park CS; Park KS; Kim ES; Cho KB
World J Gastroenterol; 2015 Oct; 21(39):11160-7. PubMed ID: 26494970
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of further expansion of the indications for endoscopic submucosal dissection in undifferentiated-type early gastric cancer.
Horiuchi Y; Ida S; Yamamoto N; Nunobe S; Ishizuka N; Yoshimizu S; Ishiyama A; Yoshio T; Hirasawa T; Tsuchida T; Kumagai K; Ohashi M; Sano T; Fujisaki J
Gastric Cancer; 2020 Mar; 23(2):285-292. PubMed ID: 31486980
[TBL] [Abstract][Full Text] [Related]
19. The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: a systematic review of the literature and meta-analysis.
Abdelfatah MM; Barakat M; Lee H; Kim JJ; Uedo N; Grimm I; Othman MO
Gastrointest Endosc; 2018 Feb; 87(2):338-347. PubMed ID: 28966062
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of gastroduodenal neuroendocrine tumors according to their WHO grade: A single-institutional retrospective analysis.
Ryu DG; Kim SJ; Choi CW; Kang DH; Kim HW; Park SB; Nam HS; Lee SH; Hwang SH
Medicine (Baltimore); 2022 Sep; 101(37):e30397. PubMed ID: 36123854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
